Dianthus Therapeutics (DNTH) Interest & Investment Income (2017 - 2025)
Dianthus Therapeutics (DNTH) posted quarterly Interest & Investment Income of $3.7 million for Q3 2025, down 17.71% year-over-year from $4.4 million in Q3 2024, and up 2226.74% quarter-over-quarter from -$172000.0 in Q2 2025.
Dianthus Therapeutics (DNTH) Interest & Investment Income (2017 - 2025) Analysis & Trends
Dianthus Therapeutics' Interest & Investment Income history runs 9 years deep, the most recent figure standing at $3.7 million for Q3 2025.
- In Q3 2025, Interest & Investment Income fell 17.71% year-over-year to $3.7 million; the TTM figure through Sep 2025 stood at $11.3 million (up 65.57% YoY), while the FY2024 annual figure was $17.4 million, up 264.5% from the prior year.
- Interest & Investment Income for Q3 2025 stood at $3.7 million, up from -$172000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $4.4 million in Q3 2024, with the low at -$172000.0 in Q2 2025.
- The 5-year median for Interest & Investment Income is $818000.0 (2021), against an average of $1.4 million.
- Peak annual rise in Interest & Investment Income reached 5222.97% in 2025, while the deepest fall reached 1620.0% in 2025.
- Dianthus Therapeutics' Interest & Investment Income stood at $848000.0 in 2021, then retreated by 24.53% to $640000.0 in 2022, then soared by 281.88% to $2.4 million in 2023, then surged by 63.26% to $4.0 million in 2024, then fell by 8.32% to $3.7 million in 2025.
- Business Quant data shows DNTH's Interest & Investment Income at $3.7 million in Q3 2025, -$172000.0 in Q2 2025, and $3.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Dianthus Therapeutics | 4.97 Bn | 4.57 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3.66 Mn |
| Jun 30, 2025 | -172,000.00 |
| Mar 31, 2025 | 3.79 Mn |
| Dec 31, 2024 | 3.99 Mn |
| Sep 30, 2024 | 4.45 Mn |
| Jun 30, 2024 | -10,000.00 |
| Mar 31, 2024 | -74,000.00 |
| Dec 31, 2023 | 2.44 Mn |
| Sep 30, 2023 | 1.03 Mn |
| Jun 30, 2023 | 687,000.00 |
| Mar 31, 2023 | 606,000.00 |
| Dec 31, 2022 | 640,000.00 |
| Sep 30, 2022 | 416,000.00 |
| Jun 30, 2022 | 812,000.00 |
| Mar 31, 2022 | 884,000.00 |
| Dec 31, 2021 | 848,000.00 |
| Sep 30, 2021 | 818,000.00 |
| Jun 30, 2021 | 682,000.00 |
| Mar 31, 2021 | 1.21 Mn |
| Dec 31, 2020 | 897,000.00 |